The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936

2003 • 2,949 citations

Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy

1999 • 878 citations

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)

2002 • 578 citations

Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia

2001 • 514 citations

Phase I Trial of Recombinant Immunotoxin Anti-Tac(Fv)-PE38 (LMB-2) in Patients With Hematologic Malignancies

2000 • 424 citations

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011

2004 • 417 citations

Cladribine (2-chlorodeoxyadenosine)

1992 • 338 citations

Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment

1998 • 318 citations

Levels of expression of CD19 and CD20 in chronic B cell leukaemias.

1998 • 315 citations

Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine

2003 • 273 citations

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

1994 • 211 citations

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia

2002 • 209 citations

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.

2000 • 170 citations

Rituximab in relapsed or refractory hairy cell leukemia

2003 • 162 citations

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia

2003 • 158 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

1998 • 157 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience

2005 • 139 citations

Eradication of minimal residual disease in hairy cell leukemia

2006 • 126 citations

An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine

2004 • 117 citations

Rituximab, a chimaeric anti‐CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

2001 • 111 citations

Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine

1994 • 110 citations

Long remissions in hairy cell leukemia with purine analogs

2005 • 110 citations

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

2003 • 107 citations

2-Chlorodeoxyadenosine: A Newer Purine Analog Active in the Treatment of Indolent Lymphoid Malignancies

1994 • 98 citations

Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.

2001 • 91 citations

Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine

1996 • 91 citations

Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine

1994 • 91 citations

Immunophenotyping and Differential Diagnosis of Hairy Cell Leukemia

2006 • 86 citations

Monoclonal Antibody Therapy of Chronic Lymphocytic Leukemia

2003 • 86 citations

Immunotherapy for Non-Hodgkin's Lymphoma: Monoclonal Antibodies and Vaccines

2005 • 85 citations

Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.

1999 • 81 citations

Current treatment options in hairy cell leukemia and hairy cell leukemia variant

2006 • 78 citations

Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.

2004 • 68 citations

The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long‐term follow‐up study

1997 • 57 citations

Deoxycoformycin in the treatment of patients with hairy cell leukemia

2000 • 56 citations

Rituximab as treatment for minimal residual disease in hairy cell leukaemia

2004 • 54 citations

Monoclonal antibody therapy of chronic lymphocytic leukemia

2005 • 48 citations

Potential Predictive Patterns of Minimal Residual Disease Detected by Immunohistochemistry on Bone Marrow Biopsy Specimens During a Long-term Follow-up in Patients Treated With Cladribine for Hairy Cell Leukemia

2006 • 44 citations

Incidence and significance of abdominal lymphadenopathy in hairy cell leukaemia.

1994 • 32 citations

Rituximab Followed by Cladribine in the Treatment of Heavily Pretreated Patients with Indolent Lymphoid Malignancies

2004 • 30 citations

Prognosis of High Dose Chemotherapy/Autologous Bone Marrow Transplantation Candidates not Receiving This Treatment after Failure of Primary Therapy of Hodgkin's Disease

1994 • 27 citations

BL22 and lymphoid malignancies

2006 • 17 citations

Hairy cell leukemia

2006 • 15 citations

Towards the pharmacotherapy of hairy cell leukaemia

2004 • 14 citations

Treatment of Resistant/Relapsing Chronic Lymphocytic Leukemia with a Combination Regimen Containing Deoxycoformycin and Rituximab

2004 • 8 citations